Last 95.50 INR
Change Today +0.60 / 0.63%
Volume 251.0
RPGL On Other Exchanges
Symbol
Exchange
Natl India
As of 11:01 PM 11/27/14 All times are local (Market data is delayed by at least 15 minutes).

rpg life sciences ltd (RPGL) Snapshot

Open
94.00
Previous Close
94.90
Day High
95.50
Day Low
94.00
52 Week High
09/10/14 - 133.58
52 Week Low
02/7/14 - 44.33
Market Cap
1.6B
Average Volume 10 Days
19.2K
EPS TTM
32.29
Shares Outstanding
16.5M
EX-Date
09/11/14
P/E TM
3.0x
Dividend
1.20
Dividend Yield
2.10%
Current Stock Chart for RPG LIFE SCIENCES LTD (RPGL)

Related News

No related news articles were found.

rpg life sciences ltd (RPGL) Related Businessweek News

No Related Businessweek News Found

rpg life sciences ltd (RPGL) Details

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic dosage forms, and synthetic and fermentation active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic/anti-depressant, anti-thrombotic, anti-anginal, anti-helmentic, anti-convulsant, anti-spasmodic, and anti-cancer. It also provides generics primarily in the area of immunosuppressant therapy; finished dosage formulations for various therapies, such as gastro-intestinal, pain management, cardio-vascular, and nephrology primarily under the Lomotil, Lomofen, Naprosyn, Azoran, Aldactone, and Serenace brand names; and biotechnology products in the areas of oncology. RPG Life Sciences Limited offers its products in various dosage forms, including tablets, capsules, and syrups. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is based in Mumbai, India.

1,200 Employees
Last Reported Date: 09/1/14
Founded in 1968

rpg life sciences ltd (RPGL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

rpg life sciences ltd (RPGL) Key Developments

Rpg Life Sciences Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

RPG Life Sciences Limited reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, net sales/income from operation was INR 566.2 million against INR 605.5 million a year ago. Loss from operation before other income, finance cost and exceptional item was INR 71.2 million against profit from operation before other income, finance cost and exceptional item of INR 11.1 million a year ago. Loss form ordinary activities before tax was INR 74.7 million against profit form ordinary activities before tax of INR 17.0 million a year ago. Net loss was INR 73.9 million or INR 4.47 per basic and diluted share against net profit of INR 22.4 million or INR 1.36 per basic and diluted share a year ago. For the six months, net sales/income from operation was INR 1,154.1 million against INR 1,234.5 million a year ago. Loss from operation before other income, finance cost and exceptional item was INR 59.2 million against profit from operation before other income, finance cost and exceptional item of INR 69.9 million a year ago. Loss form ordinary activities before tax was INR 63.7 million against profit form ordinary activities before tax of INR 710.7 million a year ago. Net loss was INR 62.3 million or INR 3.77 per basic and diluted share against net profit of INR 569.3 million or INR 34.43 per basic and diluted share a year ago.

RPG Life Sciences Limited Appoints Neera Saggi as Additional Director

RPG Life Sciences Ltd. announced that at the meeting of the Board of Directors held on October 20, 2014, Ms. Neera Saggi has been appointed as an Additional Director on the Board of the Company.

RPG Life Sciences Limited to Report Q2, 2015 Results on Oct 20, 2014

RPG Life Sciences Limited announced that they will report Q2, 2015 results on Oct 20, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RPGL:IN 95.50 INR +0.60

RPGL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RPGL.
View Industry Companies
 

Industry Analysis

RPGL

Industry Average

Valuation RPGL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.7x
Price/Book 1.3x
Price/Cash Flow 292.8x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RPG LIFE SCIENCES LTD, please visit www.rpglifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.